Chlamydia trachomatis L serovars (LGV) by PCR
Also known as: CT LGVPCR
Use
This test is used to detect the presence of Chlamydia trachomatis L1, L2, and L3 serovars, which are responsible for Lymphogranuloma Venereum (LGV), a sexually transmitted infection. This assay aids in the diagnosis of LGV, guiding appropriate treatment to prevent complications associated with untreated infections.
Special Instructions
Specimen source information is required for this test to ensure appropriate processing and interpretation. Specimens must be refrigerated during storage and transport. The test does not differentiate between the L1, L2, and L3 serovars.
Limitations
This assay has not been cleared or approved by the US Food and Drug Administration. Results should be used in conjunction with clinical findings and other laboratory tests. A negative result does not completely rule out the presence of infection because inhibition or nucleic acid levels below the detection limit can affect results.
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
LOINC Codes
- 31208-2
- 21613-5
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Vaginal Swab
Volume
Not provided
Minimum Volume
Not provided
Container
APTIMA Unisex Swab Specimen Collection kit or Viral Transport Media
Collection Instructions
Use APTIMA Unisex Swab Specimen Collection kit or Viral Transport Media. Refer to 'Sample Collection for the Diagnosis of STD' for collection instructions.
Storage Instructions
Refrigerated
Causes for Rejection
Tissues in optimal cutting temperature compound.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 month |
| Refrigerated | 1 month |
| Frozen | 1 month |
Other tests from different labs that may be relevant